Administration of an unconjugated bile acid increases duodenal tumors in a murine model of familial adenomatous polyposis.

Intestinal carcinogenesis involves the successive accumulation of multiple genetic defects until cellular transformation to an invasive phenotype occurs. This process is modulated by many epigenetic factors. Unconjugated bile acids are tumor promoters whose presence in intestinal tissues is regulated by dietary factors. We studied the role of the unconjugated bile acid, chenodeoxycholate, in an animal model of familial adenomatous polyposis. Mice susceptible to intestinal tumors as a result of a germline mutation in Apc (Min/+ mice) were given a 10 week dietary treatment with 0.5% chenodeoxycholate. Following this, the mice were examined to determine tumor number, enterocyte proliferation, apoptosis and beta-catenin expression. Intestinal tissue prostaglandin E2 (PGE2) levels were also assessed. Administration of chenodeoxycholate in the diet increased duodenal tumor number in Min/+ mice. Promotion of duodenal tumor formation was accompanied by increased beta-catenin expression in duodenal cells, as well as increased PGE2 in duodenal tissue. These data suggest that unconjugated bile acids contribute to periampullary tumor formation in the setting of an Apc mutation.

[1]  Fan Zhang,et al.  Dihydroxy Bile Acids Activate the Transcription of Cyclooxygenase-2* , 1998, The Journal of Biological Chemistry.

[2]  M. Bertagnolli,et al.  Apc gene mutation is associated with a dominant-negative effect upon intestinal cell migration. , 1997, Cancer research.

[3]  Andrew J. Dannenberg,et al.  Inhibition of Cyclooxygenase: A Novel Approach to Cancer Prevention , 1997, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[4]  Y. Monden,et al.  Effects of dietary bile acids on formation of azoxymethane-induced aberrant crypt foci in F344 rats. , 1997, Cancer letters.

[5]  R. DuBois,et al.  Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[6]  Mark Peifer,et al.  β-Catenin as Oncogene--The Smoking Gun , 1997, Science.

[7]  Bruno C. Hancock,et al.  Suppression of Intestinal Polyposis in Apc Δ716 Knockout Mice by Inhibition of Cyclooxygenase 2 (COX-2) , 1996, Cell.

[8]  K. Kinzler,et al.  Lessons from Hereditary Colorectal Cancer , 1996, Cell.

[9]  M. Bertagnolli,et al.  Cyclooxygenase-2 overexpression and tumor formation are blocked by sulindac in a murine model of familial adenomatous polyposis. , 1996, Cancer research.

[10]  M. Peifer.  Regulating Cell Proliferation--As Easy as APC , 1996, Science.

[11]  H. Handa,et al.  Induction of the transcription factor AP-1 in cultured human colon adenocarcinoma cells following exposure to bile acids. , 1996, Carcinogenesis.

[12]  R. DuBois,et al.  Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2 , 1995, Cell.

[13]  J. Lord,et al.  Expression of protein kinase C isoenzymes in colorectal cancer tissue and their differential activation by different bile acids , 1995, International journal of cancer.

[14]  S. Venitt,et al.  Bile acids do not form adducts when incubated with DNA in vitro. , 1994, Carcinogenesis.

[15]  K. Kinzler,et al.  Molecular determinants of dysplasia in colorectal lesions. , 1994, Cancer research.

[16]  B. Rigas,et al.  The effect of bile acids and piroxicam on MHC antigen expression in rat colonocytes during colon cancer development. , 1994, Immunology.

[17]  Y. Monden,et al.  In vitro formation of DNA adducts with bile acids. , 1994, Carcinogenesis.

[18]  R. Bird,et al.  The effect of chenodeoxycholic acid on the development of aberrant crypt foci in the rat colon. , 1994, Cancer letters.

[19]  G. Colditz,et al.  A meta-analysis of cholecystectomy and risk of colorectal cancer. , 1993, Gastroenterology.

[20]  S. Venitt,et al.  DNA adducts, detected by 32P-postlabelling, in DNA treated in vitro with bile from patients with familial adenomatous polyposis and from unaffected controls. , 1993, Carcinogenesis.

[21]  S. Piantadosi,et al.  Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. , 1993, The New England journal of medicine.

[22]  M. J. Hill,et al.  Biliary bile acid profiles in familial adenomatous polyposis , 1991, The British journal of surgery.

[23]  H. Pitot,et al.  A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. , 1990, Science.

[24]  J. Scholes,et al.  Effects of calcium and bile acid feeding on colon tumors in the rat. , 1989, Cancer research.

[25]  J. Guillem,et al.  The regulation of protein kinase C by chenodeoxycholate, deoxycholate and several structurally related bile acids. , 1987, Carcinogenesis.

[26]  F. DeRubertis,et al.  Role of activation of protein kinase C in the stimulation of colonic epithelial proliferation and reactive oxygen formation by bile acids. , 1987, The Journal of clinical investigation.

[27]  F. DeRubertis,et al.  Relationship between loss of rat colonic surface epithelium induced by deoxycholate and initiation of the subsequent proliferative response. , 1986, Cancer research.

[28]  F. DeRubertis,et al.  Bile salt stimulation of colonic epithelial proliferation. Evidence for involvement of lipoxygenase products. , 1984, The Journal of clinical investigation.

[29]  W. R. Bruce,et al.  Calcium ameliorates the toxic effect of deoxycholic acid on colonic epithelium. , 1983, Carcinogenesis.

[30]  W. Waddell,et al.  Sulindac for polyposis of the colon , 1983, Journal of surgical oncology.

[31]  B. Reddy.  Diet and excretion of bile acids. , 1981, Cancer research.

[32]  E. Wynder,et al.  Promoting effect of sodium deoxycholate on colon adenocarcinomas in germfree rats. , 1976, Journal of the National Cancer Institute.

[33]  P. Klein,et al.  Increased bacterial degradation of bile acids in cholecystectomized patients. , 1974, Gastroenterology.

[34]  E. Wynder,et al.  Large-bowel carcinogenesis: fecal constituents of populations with diverse incidence rates of colon cancer. , 1973, Journal of the National Cancer Institute.

[35]  M. Bertagnolli,et al.  The sulfide metabolite of sulindac prevents tumors and restores enterocyte apoptosis in a murine model of familial adenomatous polyposis. , 1998, Carcinogenesis.

[36]  G. Paumgartner,et al.  Increased serum deoxycholic acid levels in men with colorectal adenomas. , 1993, Gastroenterology.